Diagnostic News and Research

RSS

Initial results of MUSIC Trial using PD2i in chronic heart failure patients released

David H. Fater, CEO of Vicor Technologies, Inc., today announced the initial results of a study designed to analyze data from the Merte Subita en Insufficiencia Cardiaca Trial using its PD2i- algorithm and software. Vicor Technologies is a biotechnology company focused on the development of innovative, non-invasive medical devices using its patented, proprietary PD2i- nonlinear algorithm and software.

20 May 2010

Lancet special series examines TB worldwide

The Lancet released on Wednesday a special series on tuberculosis, which includes a series of papers and comments highlighting the need for new tools, the threat posed by drug-resistant strains, results of current control efforts and other issues about TB worldwide, Agence France-Presse reports.

20 May 2010

St. Jude Medical to acquire LightLab for $90M in cash

St. Jude Medical, Inc., a global medical device company, and LightLab Imaging, Inc. today announced a definitive agreement under which St. Jude Medical will acquire LightLab, a subsidiary of Goodman Co., Ltd. for approximately $90 million in cash.

20 May 2010

AACE, AME and ETA jointly publish guidelines for diagnosis and management of thyroid nodules

Three of the world's most respected medical associations for the treatment of thyroid disease recently issued joint guidelines for the diagnosis and management of thyroid nodules. The American Association of Clinical Endocrinologists, the Associazione Medici Endocrinologi and European Thyroid Association jointly published the guidelines online this week, and the executive summary will be published in the next issue of their respective journals.

20 May 2010

ImaginAb, GSK CIC conclude two research collaboration agreements

ImaginAb, Inc. and the GSK Clinical Imaging Centre (part of the GlaxoSmithKline Group of Companies) have concluded two research collaboration agreements around a clinical therapeutic antibody asset currently under development by GSK in the field of oncology.

20 May 2010

FDA grants 510(k) market clearance for EraGen's MultiCode-RTx HSV 1&2 Kit

EraGen Biosciences Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance for EraGen's MultiCode®-RTx HSV 1&2 Kit.

20 May 2010

Diagnostic change not enough to help children diagnosed with bipolar disorder

Shifting children from the controversial diagnosis of bipolar disorder to one that more accurately reflects their symptoms will not by itself decrease the rate of psychopharmacologic treatment and is not enough to help troubled children flourish, according to a commentary in the May 20, 2010 issue of the New England Journal of Medicine by researchers at The Hastings Center, a bioethics research institute, and a physician-researcher at Stony Brook University School of Medicine.

19 May 2010

Rosetta Genomics announces publication of study on discovery of microRNAs in solid tumors

Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostic tests, announces the publication of a study entitled, "Discovery of microRNAs and other small RNAs in solid tumors," in the online edition of Nucleic Acid Research.

19 May 2010

Alere announces formation of Collaborative Care Solutions to support physicians, provider groups

With the goal of creating the industry standard for connecting patients and their physician-led care teams, Alere today announced the formation of a new strategic product line, Collaborative Care Solutions. The new product line will be focused on supporting physicians and provider groups wanting to expand their practices via patient-centered medical homes or accountable care organizations -- key care models designed to realize better outcomes and more cost-effective care.

19 May 2010

Study examines impact of APOE ε4 on cognitive function, brain anatomy in AD patients

In the most comprehensive study to date, neurologists have clearly identified significant differences in the ways that Alzheimer's disease affects patients with and without the apolipoprotein E ε4 gene, a known genetic risk factor for the neurodegenerative disease, using a combination of cognitive and neuroanatomic measures. The study found that this gene influences the way the disease manifests, even at its mildest clinical stages.

19 May 2010

VRAD's total revenue increased 8% to $30.8M for quarter ended March 31, 2010

MicroStockProfit.com announces an investment report featuring Virtual Radiologic Corp. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

19 May 2010

New book on history and future of medical technology

Some health care reform advocates complain that physicians rely too much on expensive technology. Published by Telescope Books, The History and Future of Medical Technology shows that today's medical technologies are worth every penny—saving lives, improving patients' quality of life, and helping doctors diagnose diseases during the earliest, most treatable stages.

19 May 2010

Neuro Kinetics releases new version of VEST control and analysis software

Neuro Kinetics, Inc., manufacturers of noninvasive medical diagnostic equipment used worldwide to test for neuro-otologic, vestibular and neurological dysfunctions, said today that it has released version 6.8 of its VEST control and analysis software.

19 May 2010

Two common operations for SUI help women achieve similar levels of dryness: Study

Two common operations for stress urinary incontinence help women achieve similar levels of dryness, according to a team of urologists and urogynecologists who compared the treatments in a large U.S. trial supported by the National Institutes of Health. The study is being released online May 17, 2010, by the New England Journal of Medicine to coincide with a presentation at the annual meeting of the American College of Obstetrics and Gynecology. Results will appear in the June 3 print edition.

19 May 2010

New test to detect HBV receives regulatory approval for use in the European Union

An inexpensive new test for the detection of Hepatitis B virus has been given regulatory approval for use in the European Union. The test, developed with support from the Wellcome Trust, delivers accurate results while-you-wait, enabling doctors to take immediate action on health decisions.

19 May 2010

Causes and treatment options of mental disorders need to be reassessed: JAMA commentary

It is time to reassess mental disorders, recognizing that these are disorders of brain circuits likely caused by development processes, according to a commentary in the May 19 issue of JAMA, a theme issue on mental health.

19 May 2010

FDA grants Illumina 510(k) clearance for VeraCode Genotyping Test for Factor V and Factor II

Illumina, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance for the VeraCode® Genotyping Test for Factor V (Leiden) and Factor II (Prothrombin).

From Illumina, Inc. 19 May 2010

Medico's Hirata to distribute Accumetrics' VerifyNow System in Japan

Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed a new agreement with Medico's Hirata for distribution of its VerifyNow System in Japan.

18 May 2010

Warnings about a ruined appearance is best way to reduce tanning salon visits

What's the most effective way to convince young women to cut back on their indoor tanning, a habit that hikes their risk of melanoma, the deadliest form of skin cancer, by 75 percent? Warn them that it will cause leathery, wrinkled skin.

18 May 2010

Study reviews impact of focal therapy for low-risk prostate cancer patients

In the July issue of European Urology, the scientific journal of the European Association of Urology, the significance and impact of focal therapy for low-risk cancer patients is discussed in a recent study by S. Eggener et al.

18 May 2010

Diagnostic News and Research

Initial results of MUSIC Trial using PD2i in chronic heart failure patients released

Lancet special series examines TB worldwide

St. Jude Medical to acquire LightLab for $90M in cash

AACE, AME and ETA jointly publish guidelines for diagnosis and management of thyroid nodules

ImaginAb, GSK CIC conclude two research collaboration agreements

FDA grants 510(k) market clearance for EraGen's MultiCode-RTx HSV 1&2 Kit

Diagnostic change not enough to help children diagnosed with bipolar disorder

Rosetta Genomics announces publication of study on discovery of microRNAs in solid tumors

Alere announces formation of Collaborative Care Solutions to support physicians, provider groups

Study examines impact of APOE ε4 on cognitive function, brain anatomy in AD patients

VRAD's total revenue increased 8% to $30.8M for quarter ended March 31, 2010

New book on history and future of medical technology

Neuro Kinetics releases new version of VEST control and analysis software

Two common operations for SUI help women achieve similar levels of dryness: Study

New test to detect HBV receives regulatory approval for use in the European Union

Causes and treatment options of mental disorders need to be reassessed: JAMA commentary

FDA grants Illumina 510(k) clearance for VeraCode Genotyping Test for Factor V and Factor II

Medico's Hirata to distribute Accumetrics' VerifyNow System in Japan

Warnings about a ruined appearance is best way to reduce tanning salon visits

Study reviews impact of focal therapy for low-risk prostate cancer patients

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News